Ipratropium bromide is a muscarinic receptor antagonist, demonstrating IC50s of 2.9 nM for M1, 2 nM for M2, and 1.7 nM for M3 receptors. This compound effectively relaxes smooth muscle and is utilized in research focusing on conditions such as chronic obstructive pulmonary disease (COPD) and asthma.
- Targets mAChR
- Supports neurological disease and inflammation/immunology research
- Acts as a muscarinic receptor antagonist
- Exhibits IC50 values of 2.9 nM for M1, 2 nM for M2, and 1.7 nM for M3 receptors
- Relaxes smooth muscle
- Suitable for research on chronic obstructive pulmonary disease (COPD) and asthma